AILSE ONCOLOGY

• 74909 - Other professional, scientific and technical activities n.e.c.

Evgen Pharma is a clinical stage drug development company developing sulforaphane-based medicines focussed on the treatment of cancer and inflammation. Our pipeline and lead compound SFX-01 is derived from our proprietary Sulforadex® technology. We are also researching a number of synthetic, stabilised analogues of the naturally occurring compound sulforaphane. Many peer-reviewed scientific papers have identified the medical potential of sulforaphane in multiple indications. Our objective is to turn this scientific promise into commercially successful products, addressing important clinical needs.

Also known as: AILSE ONCOLOGY LTD.

Registration numbers: 09568829 (CH)

Primary location: Macclesfield United Kingdom